Wilson Sonsini Goodrich & Rosati’s 2021 Technology and Life Sciences IPO Half-Year Report provides analysis of the pricing of 123 IPOs completed between January 1 and June 30, 2021 by US technology and life sciences companies were price and value statistics for both sectors; Corporate governance details; Property and structural factors; and defense measure data points. The report also briefly discusses concurrent private placements, expressions of interest, direct listings and special purpose vehicles.
The first half of 2021 has proven to be the most active first half of a year for IPOs in technology and life sciences since the high levels reached during the dot-com era in the late 1990s. As 2020 came to an end and ended a surprisingly robust year in which, despite the pandemic, there were unexpectedly many IPOs in the technology and life sciences sectors, the number of IPOs began by leaps and bounds in early 2021 and has since increased at a rapid pace with technology- Sciences IPOs are weekly at fixed prices. Comparing the first six months of 2021 IPO activity to the same timeframe discussed in the company’s 2020 year-end IPO report, the total number of IPOs in the first six months of this year is nearly four times the total number of IPOs. In short, 2021 is a record year so far for technology and life sciences IPOs.
See the full report below for more information.